Overexpression of HA-Bax but not Bcl-2 or Bcl-X(L) attenuates 6- hydroxydopamine-induced neuronal apoptosis

Experimental Neurology

Volumn 154, Issue 1, 1998, Pages 193-198

  Oh, Jae H ^a   Choi, Won Seok ^a   Kim, Ji Eun ^a   Seo, Jung Woo ^a   O'Malley, Karen L ^b   Oh, Young J ^a  

^a Yonsei University   (South Korea)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

6 hydroxydopamine; Apoptosis; Bax; Caspase; Dopaminergic neuron

Indexed keywords

OXIDOPAMINE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DEGRADATION; DNA DETERMINATION; DOPAMINERGIC NERVE CELL; IMMUNOBLOTTING; NERVE CELL NECROSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0032211304     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6923     Document Type: Article

References (41)

1. Beal M. F. Mitochondria, free radicals, and neurodegeneration. Curr. Opin. Neurobiol. 6:1996;661-666.
2. L. Biochem. J. 325:1997;315-319.
3. Bottenstein J., Hayashi I., Hutchings S., Masui H., Mather J., McClure D. B., Ohasa S., Rizzino A., Sato G., Serrero G., Wolfe R., Wu R. The growth of cells in serum-free hormone-supplemented media. Methods Enzymol. 58:1979;94-109.
4. Choi H. K., Won L. A., Kontur P. J., Hammond D. N., Fox A. P., Wainer B. H., Hoffmann P. C., Heller A. Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res. 552:1991;67-76.
5. Doroshow J. H. Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones. Proc. Natl. Acad. Sci. USA. 83:1986;4514-4518.
6. Ellerby L. M., Ellerby H. M., Park S. M., Holleran A. L., Murphy A. N., Fiskum G., Kane D. J., Testa M. P., Kayalar C., Bredesen D. E. Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2. J. Neurochem. 67:1996;1259-1267.
7. L. J. Immunol. 155:1995;66-75.
8. Gerlach M., Riederer P. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man. J. Neural Transm. 103:1996;987-1041.
9. Glinka Y., Gassen M., Youdim M. B. Mechanism of 6-hydroxydopamine neurotoxicity. J. Neural Transm. 50:1997;55-66.
10. Greenlund L. J. S., Deckwerth T. L., Johnson E. M. Jr. Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death. Neuron. 14:1995;303-315.
11. Hansen M. B., Nielson S. E., Berg K. Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods. 119:1989;203-210.
12. Hockenbery D. M., Nunez G., Milliman C., Schreiber R. D., Korsmeyer S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348:1990;334-336.
13. Hockenbery D. M., Oltvai Z. N., Yin X. M., Milliman C. L., Korsmeyer S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
14. Jacobson M. D., Raff M. C. Programmed cell death and Bcl-2 protection in very low oxygen. Nature. 374:1995;814-816.
15. Jacobson M. D., Weil M., Korsmeyer S. J. Programmed cell death in animal development. Cell. 88:1997;347-354.
16. Kane D. J., Sarafian T. A., Anton R., Hahn H., Gralla E. B., Valentine S. J., Ord T., Bredesen D. E. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science. 262:1993;1274-1277.
17. Kiefer M. C., Brauer M. J., Powers V. C., Wu J. J., Umansky S. R., Tomei L. D., Barr P. J. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature. 374:1995;736-739.
18. Knudson C. M., Tung K. S. K., Tourtellotte W. G., Brown G. A. J., Korsmeyer S. J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science. 270:1995;96-99.
19. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3:1997;614-620.
20. Marti M. J., James C. J., Oo T. F., Kelly W. J., Burke R. E. Early developmental destruction of terminals in the striatal target induces apoptosis in dopaminergic neurons of the substantia nigra. J. Neurosci. 17:1997;2030-2039.
21. Martin S. J., Green D. R. Protease activation during apoptosis: death by a thousand cuts. Cell. 82:1995;349-352.
22. Middleton G., Nunez G., Davies A. M. Bax promotes neuronal survival and antagonises the survival effects of neurotrophic factors. Development. 122:1996;695-701.
23. Mochizuki H., Goto K., Mori H., Mizuno Y. Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137:1996;120-123.
24. +. Neurobiol. Dis. 2:1995;157-167.
25. Oh Y. J., Choi W. S., Oh J. H., O'Malley K. L., Reed J. C. Role of cell death-regulating genes in two distinct cell death paradigms of dopaminergic neuronal cell line. Soc. Neurosci. 23:1997;632.
26. Oh J. H., O'Malley K. L., Krajewski S., Reed J. C., Oh Y. J. Bax accelerates staurosporine-induced but suppresses nigericin-induced neuronal cell death. NeuroReport. 8:1997b;1851-1856.
27. Oh Y. J., Uhland-Smith A., Kim J.-E., O'Malley K. L. Regions outside of the Bcl-2 homology domains, BH1 and BH2 protect a dopaminergic neuronal cell line from staurosporine-induced cell death. Mol. Brain Res. 51:1997c;133-142.
28. Olanow C. W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:1993;439-444.
29. Oltvai Z. N., Milliman C. L., Korsmeyer S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
30. Reed J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1994;1-6.
31. Reed J. C. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
32. Shearman M. S., Ragan C. I., Iversen L. L. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA. 91:1994;1470-1474.
33. L. Nature. 374:1995;811-813.
34. Tipton K. F., Singer T. P. Advances in our understanding of the mechanisms of neurotoxicity of MPTP and related compounds. J. Neurochem. 61:1993;1191-1206.
35. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
36. Thor H., Smith M. T., Hartzell P., Bellomo G., Jewell S. A., Orrenius S. The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. J. Biol. Chem. 257:1982;12419-12425.
37. Tompkins M. M., Basgall E. J., Zamrini E., Hill W. D. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am. J. Pathol. 150:1997;119-131.
38. Walkinshaw G., Waters C. M. Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience. 63:1994;975-987.
39. White E. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1996;1-15.
40. Xiang J., Chao D. T., Korsmeyer S. J. Bax-induced cell death may not require interleukin 1b-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA. 93:1996;14559-14563.
41. Yang E., Korsmeyer S. J. Molecular thanatopsis: a discourse on the Bcl-2 family and cell death. Blood. 88:1996;386-401.